Yoshihiro Tominaga

Author PubWeight™ 33.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 2009 2.10
2 Kidney volume changes in patients with autosomal dominant polycystic kidney disease after renal transplantation. Transplantation 2012 1.54
3 Bone formation by minimodeling is more active than remodeling after parathyroidectomy. Kidney Int 2008 1.42
4 Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism. Am J Kidney Dis 2004 1.29
5 Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients. Nephrol Dial Transplant 2003 1.29
6 Recurrent renal hyperparathyroidism caused by parathyromatosis. World J Surg 2007 1.07
7 Effects of serum calcium, phosphorous, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan. Ther Apher Dial 2008 1.06
8 Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism. Am J Kidney Dis 2003 0.97
9 EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease. J Am Soc Nephrol 2008 0.97
10 Increased osteocyte death and mineralization inside bone after parathyroidectomy in patients with secondary hyperparathyroidism. J Bone Miner Res 2010 0.88
11 Incidence of parathyroid glands located in thymus in patients with renal hyperparathyroidism. World J Surg 2008 0.87
12 QuiCk-IntraOperative Bio-Intact PTH assay at parathyroidectomy for secondary hyperparathyroidism. World J Surg 2007 0.85
13 Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Transplantation 2003 0.85
14 Comparison between whole and intact parathyroid hormone assays. Ther Apher Dial 2011 0.85
15 Cases with fewer than four parathyroid glands in patients with renal hyperparathyroidism at initial parathyroidectomy. World J Surg 2001 0.85
16 Circadian blood pressure rhythm is disturbed by nephrectomy. Hypertens Res 2005 0.84
17 Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients; special focus on dilated cardiomyopathy. Clin Exp Nephrol 2005 0.83
18 Minimodeling reduces the rate of cortical bone loss in patients with secondary hyperparathyroidism. Am J Kidney Dis 2007 0.82
19 A Retrospective Study of the Impact of Intraoperative Intact Parathyroid Hormone Monitoring During Total Parathyroidectomy for Secondary Hyperparathyroidism: STARD Study. Medicine (Baltimore) 2015 0.82
20 Significance of time-course changes of serum bone markers after parathyroidectomy in patients with uraemic hyperparathyroidism. Nephrol Dial Transplant 2007 0.82
21 Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl. NDT Plus 2008 0.81
22 1,25-dihydroxyvitamin D synthesis after renal transplantation: the role of fibroblast growth factor 23 and cyclosporine. Clin Transplant 2009 0.80
23 Restored cardiac conditions and left ventricular function after parathyroidectomy in a hemodialysis patient. Parathyroidectomy improves cardiac fatty acid metabolism assessed by 123I-BMIPP. Circ J 2009 0.80
24 Reoperation for renal hyperparathyroidism. World J Surg 2002 0.79
25 Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial. Ther Apher Dial 2006 0.79
26 Development of immunoassays for type-5 tartrate-resistant acid phosphatase in human serum. Clin Chim Acta 2003 0.78
27 Relationship between the dimension of parathyroid glands estimated by ultrasonography and the hyperplastic pattern in patients with renal hyperparathyroidism. Ther Apher Dial 2008 0.78
28 Tertiary hyperparathyroidism resistant to cinacalcet treatment. Ther Apher Dial 2011 0.77
29 Calciphylaxis: a rare complication of patients who required parathyroidectomy for advanced renal hyperparathyroidism. World J Surg 2005 0.77
30 Surgical significance of undescended parathyroid gland in renal hyperparathyroidism. Surgery 2006 0.77
31 Immunocytochemical analysis for differential diagnosis of thyroid lesions using liquid-based cytology. Nagoya J Med Sci 2011 0.77
32 Infarction of mediastinal parathyroid gland causing spontaneous remission of secondary hyperparathyroidism. Am J Kidney Dis 2004 0.76
33 Hypocalcemia immediately after renal transplantation. Clin Transplant 2013 0.76
34 Molecular basis of parathyroid hyperplasia. J Ren Nutr 2007 0.76
35 Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study. Ther Apher Dial 2014 0.76
36 Impact of lanthanum carbonate on cortical bone in dialysis patients with adynamic bone disease. Ther Apher Dial 2013 0.76
37 Parathyroidectomy markedly reduces oxidative stress in a patient with primary hyperparathyroidism. Ther Apher Dial 2011 0.76
38 How to estimate kidney function in kidney transplant recipients with mild to moderate kidney impairment: comparison of estimated glomerular filtration (eGFR) values between creatinine-based GFR equations and cystatin C-based GFR equations for Japanese population. Clin Exp Nephrol 2013 0.75
39 Up-regulation of the gene encoding protein kinase A type I alpha regulatory subunit in nodular hyperplasia of parathyroid glands in patients with chronic renal failure. J Clin Endocrinol Metab 2005 0.75
40 New clinical guidelines for selective direct injection therapy of the parathyroid glands in chronic dialysis patients. NDT Plus 2008 0.75
41 Autoinfarction of the parathyroid gland diagnosed by power Doppler ultrasonography in a patient with secondary hyperparathyroidism. Nephrol Dial Transplant 2005 0.75
42 [A hemodialysis patient with secondary hyperparathyroidism in whom primary parathyroid adenoma was resected 27 years previously]. Nihon Jinzo Gakkai Shi 2003 0.75
43 Role of multifunctional cell cycle modulators in advanced secondary hyperparathyroidism. Ther Apher Dial 2011 0.75
44 A case report of a renal transplant recipient developing chronic glomerular rejection with a weak antibody against anti-donor T-cell, only detected by flow-cytometry crossmatch. Clin Transplant 2003 0.75
45 Beneficial effects of preemptive kidney transplantation on calcium and phosphorus disorders in early post-transplant recipients. Clin Exp Nephrol 2014 0.75
46 [Early administration of vitamin D and maintenance therapy of secondary hyperparathyroidism: discussion]. Clin Calcium 2006 0.75
47 [Usefulness of power Doppler ultrasonography for the diagnosis of autoinfarction of parathyroid gland in secondary hyperparathyroidism]. Clin Calcium 2005 0.75
48 [Present status and problems in vitamin D and sevelamer therapy (discussion)]. Clin Calcium 2005 0.75
49 [Two patients with hyperparathyroidism which was progressive for more than ten years after successful kidney transplantation]. Clin Calcium 2005 0.75
50 A supernumerary parathyroid gland located in an unusual site, parapharyngeal space, in a patient with persistent renal hyperparathyroidism. Nephrol Dial Transplant 2007 0.75
51 [Morphological analysis of bone dynamics and metabolic bone disease. A case report of recurrent renal hyperparathyroidism]. Clin Calcium 2011 0.75
52 Modified laparoscopic splenectomy: a beneficial technique for ABO-incompatible living donor renal transplantation candidates on hemodialysis. Ther Apher Dial 2008 0.75